Substituted tetracycline compounds
AssigneeParatek Pharmaceuticals, Inc.
InventorsMark L. Nelson, Peter Viski, Jackson Chen, Tadeusz Warchol
Life of this patent
Estimating the term…
Abstract
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Claims14
A compound selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
A compound selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
A compound selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
A compound selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.